CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health (NYSE: CVS) has announced the availability of the Moderna COVID-19 booster shot at select CVS Pharmacy locations starting October 22, 2021. This follows CDC authorization and guidance from the Advisory Committee on Immunization Practices (ACIP). Eligible populations include individuals aged 65 and older, those aged 50-64 with underlying health conditions, and others aged 18-49 at high risk. CVS has administered over 34 million COVID-19 vaccines to date and is prepared to expand vaccine eligibility to ages 5-11 upon CDC approval.
The Aetna Connected Plan with CVS Health is an innovative health care offering in the New York/New Jersey market, providing members with a more affordable way to access care. This plan combines the Aetna Open Access network with expanded services at CVS Pharmacy, featuring over 800 locations and 53 CVS HealthHUBs.
Mid-sized businesses can start quoting for the plan now, effective from December 2021. Key benefits include $0 copays at in-network clinics, 90-day prescription refills, and valuable support through Care Concierge services.
CVS Health has announced a quarterly dividend of $0.50 per share, approved by its board of directors. The dividend will be payable on November 1, 2021, to shareholders of record by October 22, 2021. This reflects the company's commitment to returning value to its shareholders.
CVS Health Corporation (NYSE: CVS) will host a conference call on November 3, 2021, at 8:00 a.m. (ET) to discuss its third-quarter 2021 financial results. An audio webcast will be available through the CVS Health Investor Relations website, providing access to interested parties. The webcast will be archived for a year. CVS Health is recognized for delivering comprehensive health solutions, with over 300,000 employees, including more than 40,000 physicians and healthcare professionals, enhancing community health access and affordability.
Aetna, a CVS Health company, announced its 2022 Medicare offerings, emphasizing expanded benefits aimed at improving member health and affordability. With nearly 9.8 million Medicare members, Aetna introduced more than 2.9 million beneficiaries to new Medicare Advantage plans, including $0 premium options available to 84% of eligible beneficiaries. The plans now cover 46 states and D.C., with access extended to additional counties, impacting 53.2 million individuals. Aetna also expanded benefits for Dual Eligible Special Needs Plans and designed specialized coverage for Veterans, addressing social determinants of health.
CVS Health (NYSE: CVS) announced the availability of the Pfizer-BioNTech COVID-19 booster shot starting September 24, 2021, following CDC approval. Eligible populations include individuals 65 and older, those 50-64 with specific medical conditions, and those 18-49 at high risk for severe COVID-19. CVS has administered over 34 million COVID-19 vaccines to date and continues to expand its vaccination efforts, preparing to offer additional booster shots as authorized. CVS encourages appointments for efficiency and accessibility.
CVS Health (NYSE: CVS) is hosting a national career event on September 24, 2021, aiming to recruit 25,000 clinical and retail positions. This initiative is in response to an expected increase in flu cases and ongoing COVID-19 vaccination and testing demand. Most roles include full-time and part-time licensed pharmacists, pharmacy technicians, and nurses. CVS has administered over 34 million COVID-19 vaccines and 32 million tests. The hiring process will be entirely virtual, promoting accessibility for applicants. CVS continues to invest in its workforce with competitive pay and benefits.
CVS Health (NYSE: CVS) announced that President and CEO Karen S. Lynch and Executive Vice President Alan Lotvin, M.D., will participate in a fireside chat at the 19th Annual Morgan Stanley Global Healthcare Conference on September 14, 2021, at approximately 8:45 am ET. This event highlights CVS Health's commitment to enhancing community health through its extensive services, including its teams of healthcare professionals. For more information, visit www.cvshealth.com.
CVS Health has opened its first MinuteClinic locations in Washington as part of its nationwide expansion strategy. The MinuteClinic offers affordable healthcare for patients aged 18 months and older, providing services such as diagnosis, treatment, and prescriptions for common illnesses. The new locations are integrated with CVS HealthHUB™, enhancing patient experience with a variety of clinical services. Virtual consultations are also available through the E-Clinic. Most major health insurances are accepted, with transparent pricing for cash or credit patients.
CVS Health Corporation has announced the pricing details for its cash tender offer for up to $2,049,919,000 of its 4.300% Senior Notes due 2028. The tender offer, initiated on August 9, 2021, will allow holders to receive a total consideration of $1,162.08 per $1,000 principal amount of notes tendered, including an early tender payment of $30. The early tender date was August 20, 2021, with settlement expected on August 24, 2021.